Page last updated: 2024-09-04

beta-lactams and daunorubicin

beta-lactams has been researched along with daunorubicin in 1 studies

Compound Research Comparison

Studies
(beta-lactams)
Trials
(beta-lactams)
Recent Studies (post-2010)
(beta-lactams)
Studies
(daunorubicin)
Trials
(daunorubicin)
Recent Studies (post-2010) (daunorubicin)
7,5791793,3958,2398861,310

Protein Interaction Comparison

ProteinTaxonomybeta-lactams (IC50)daunorubicin (IC50)
72 kDa type IV collagenaseHomo sapiens (human)1.9
Multidrug resistance-associated protein 1 Homo sapiens (human)8
Histone deacetylase 1Homo sapiens (human)0.047
Histone deacetylase 8Homo sapiens (human)0.22
Histone deacetylase 6Homo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, G; Li, B; Li, J; Liu, X; Pan, XC; Ran, D; Wang, N; Wu, C; Yao, Q; Zhang, R; Zheng, J; Zhou, H1

Other Studies

1 other study(ies) available for beta-lactams and daunorubicin

ArticleYear
Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:4

    Topics: Anti-Bacterial Agents; Artemisinins; Artesunate; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Daunorubicin; Drug Synergism; Escherichia coli; Escherichia coli Proteins; Gene Expression Profiling; Lipoproteins; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins

2011